|  Help  |  About  |  Contact Us

Search our database by keyword

- or -

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 201 to 300 out of 329 for Pbsn

Category restricted to Publication (x)

0.462s

Categories

Category: Publication
Type Details Score
Publication
First Author: Ding L
Year: 2014
Journal: Cancer Res
Title: CBP loss cooperates with PTEN haploinsufficiency to drive prostate cancer: implications for epigenetic therapy.
Volume: 74
Issue: 7
Pages: 2050-61
Publication
First Author: Fu Y
Year: 2008
Journal: Proc Natl Acad Sci U S A
Title: Pten null prostate tumorigenesis and AKT activation are blocked by targeted knockout of ER chaperone GRP78/BiP in prostate epithelium.
Volume: 105
Issue: 49
Pages: 19444-9
Publication
First Author: Adisetiyo H
Year: 2013
Journal: PLoS One
Title: Loss of survivin in the prostate epithelium impedes carcinogenesis in a mouse model of prostate adenocarcinoma.
Volume: 8
Issue: 7
Pages: e69484
Publication
First Author: Leav I
Year: 2010
Journal: Am J Pathol
Title: Cytoprotective mitochondrial chaperone TRAP-1 as a novel molecular target in localized and metastatic prostate cancer.
Volume: 176
Issue: 1
Pages: 393-401
Publication
First Author: Penfold L
Year: 2023
Journal: Cell Rep
Title: AMPK activation protects against prostate cancer by inducing a catabolic cellular state.
Volume: 42
Issue: 4
Pages: 112396
Publication
First Author: Mi J
Year: 2018
Journal: J Biol Chem
Title: Activation of hepatocyte growth factor/MET signaling initiates oncogenic transformation and enhances tumor aggressiveness in the murine prostate.
Volume: 293
Issue: 52
Pages: 20123-20136
Publication    
First Author: Germanos AA
Year: 2022
Journal: Elife
Title: Defining cellular population dynamics at single-cell resolution during prostate cancer progression.
Volume: 11
Publication
First Author: Zhang Q
Year: 2012
Journal: Cancer Res
Title: Interleukin-17 promotes formation and growth of prostate adenocarcinoma in mouse models.
Volume: 72
Issue: 10
Pages: 2589-99
Publication
First Author: Labbé DP
Year: 2016
Journal: Cancer Res
Title: PTP1B Deficiency Enables the Ability of a High-Fat Diet to Drive the Invasive Character of PTEN-Deficient Prostate Cancers.
Volume: 76
Issue: 11
Pages: 3130-5
Publication
First Author: Wang S
Year: 2012
Journal: Carcinogenesis
Title: Effect of dietary polyunsaturated fatty acids on castration-resistant Pten-null prostate cancer.
Volume: 33
Issue: 2
Pages: 404-12
Publication
First Author: Ruscetti M
Year: 2016
Journal: Oncogene
Title: HDAC inhibition impedes epithelial-mesenchymal plasticity and suppresses metastatic, castration-resistant prostate cancer.
Volume: 35
Issue: 29
Pages: 3781-95
Publication
First Author: Chen M
Year: 2012
Journal: J Pathol
Title: Loss of epithelial oestrogen receptor α inhibits oestrogen-stimulated prostate proliferation and squamous metaplasia via in vivo tissue selective knockout models.
Volume: 226
Issue: 1
Pages: 17-27
Publication
First Author: Wu L
Year: 2019
Journal: Cancer Res
Title: Loss of FOXP3 and TSC1 Accelerates Prostate Cancer Progression through Synergistic Transcriptional and Posttranslational Regulation of c-MYC.
Volume: 79
Issue: 7
Pages: 1413-1425
Publication
First Author: Ding M
Year: 2018
Journal: Mol Cancer Res
Title: The mTOR Targets 4E-BP1/2 Restrain Tumor Growth and Promote Hypoxia Tolerance in PTEN-driven Prostate Cancer.
Volume: 16
Issue: 4
Pages: 682-695
Publication
First Author: Nacerddine K
Year: 2012
Journal: J Clin Invest
Title: Akt-mediated phosphorylation of Bmi1 modulates its oncogenic potential, E3 ligase activity, and DNA damage repair activity in mouse prostate cancer.
Volume: 122
Issue: 5
Pages: 1920-32
Publication
First Author: Lu W
Year: 2017
Journal: Oncogene
Title: SKP2 loss destabilizes EZH2 by promoting TRAF6-mediated ubiquitination to suppress prostate cancer.
Volume: 36
Issue: 10
Pages: 1364-1373
Publication
First Author: Oberhuber M
Year: 2020
Journal: Mol Syst Biol
Title: STAT3-dependent analysis reveals PDK4 as independent predictor of recurrence in prostate cancer.
Volume: 16
Issue: 4
Pages: e9247
Publication
First Author: Bjerke GA
Year: 2014
Journal: Oncogene
Title: Activation of Akt signaling in prostate induces a TGFβ-mediated restraint on cancer progression and metastasis.
Volume: 33
Issue: 28
Pages: 3660-7
Publication
First Author: Bjerke GA
Year: 2014
Journal: PLoS One
Title: Prostate cancer induced by loss of Apc is restrained by TGFβ signaling.
Volume: 9
Issue: 3
Pages: e92800
Publication
First Author: Birbach A
Year: 2013
Journal: PLoS One
Title: Use of PB-Cre4 mice for mosaic gene deletion.
Volume: 8
Issue: 1
Pages: e53501
Publication
First Author: Limberger T
Year: 2022
Journal: Mol Cancer
Title: KMT2C methyltransferase domain regulated INK4A expression suppresses prostate cancer metastasis.
Volume: 21
Issue: 1
Pages: 89
Publication  
First Author: Wise HM
Year: 2022
Journal: Biomolecules
Title: PTEN Protein Phosphatase Activity Is Not Required for Tumour Suppression in the Mouse Prostate.
Volume: 12
Issue: 10
Publication
First Author: Jayaprakash P
Year: 2018
Journal: J Clin Invest
Title: Targeted hypoxia reduction restores T cell infiltration and sensitizes prostate cancer to immunotherapy.
Volume: 128
Issue: 11
Pages: 5137-5149
Publication
First Author: Zabala-Letona A
Year: 2017
Journal: Nature
Title: mTORC1-dependent AMD1 regulation sustains polyamine metabolism in prostate cancer.
Volume: 547
Issue: 7661
Pages: 109-113
Publication
First Author: Shenoy TR
Year: 2017
Journal: Ann Oncol
Title: CHD1 loss sensitizes prostate cancer to DNA damaging therapy by promoting error-prone double-strand break repair.
Volume: 28
Issue: 7
Pages: 1495-1507
Publication
First Author: Chung WC
Year: 2020
Journal: Am J Pathol
Title: PIK3CG Is a Potential Therapeutic Target in Androgen Receptor-Indifferent Metastatic Prostate Cancer.
Volume: 190
Issue: 11
Pages: 2194-2202
Publication
First Author: Chen J
Year: 2018
Journal: Nat Genet
Title: Compartmentalized activities of the pyruvate dehydrogenase complex sustain lipogenesis in prostate cancer.
Volume: 50
Issue: 2
Pages: 219-228
Publication
First Author: DeGraff DJ
Year: 2014
Journal: Lab Invest
Title: FOXA1 deletion in luminal epithelium causes prostatic hyperplasia and alteration of differentiated phenotype.
Volume: 94
Issue: 7
Pages: 726-39
Publication
First Author: Furic L
Year: 2010
Journal: Proc Natl Acad Sci U S A
Title: eIF4E phosphorylation promotes tumorigenesis and is associated with prostate cancer progression.
Volume: 107
Issue: 32
Pages: 14134-9
Publication
First Author: Kovalenko PL
Year: 2011
Journal: Cancer Prev Res (Phila)
Title: Dietary vitamin D and vitamin D receptor level modulate epithelial cell proliferation and apoptosis in the prostate.
Volume: 4
Issue: 10
Pages: 1617-25
Publication
First Author: Ding D
Year: 2023
Journal: Nat Commun
Title: Gain-of-function mutant p53 together with ERG proto-oncogene drive prostate cancer by beta-catenin activation and pyrimidine synthesis.
Volume: 14
Issue: 1
Pages: 4671
Publication
First Author: Yang Y
Year: 2017
Journal: Cancer Res
Title: Loss of FOXO1 Cooperates with TMPRSS2-ERG Overexpression to Promote Prostate Tumorigenesis and Cell Invasion.
Volume: 77
Issue: 23
Pages: 6524-6537
Publication
First Author: Fleet JC
Year: 2019
Journal: Cancer Prev Res (Phila)
Title: Vitamin D Signaling Suppresses Early Prostate Carcinogenesis in TgAPT(121) Mice.
Volume: 12
Issue: 6
Pages: 343-356
Publication
First Author: Zanconato F
Year: 2016
Journal: Cancer Cell
Title: YAP/TAZ at the Roots of Cancer.
Volume: 29
Issue: 6
Pages: 783-803
Publication
First Author: Guccini I
Year: 2021
Journal: Cancer Cell
Title: Senescence Reprogramming by TIMP1 Deficiency Promotes Prostate Cancer Metastasis.
Volume: 39
Issue: 1
Pages: 68-82.e9
Publication  
First Author: Wang ME
Year: 2023
Journal: J Clin Invest
Title: RB1-deficient prostate tumor growth and metastasis are vulnerable to ferroptosis induction via the E2F/ACSL4 axis.
Volume: 133
Issue: 10
Publication
First Author: Cecena G
Year: 2006
Journal: Am J Pathol
Title: Differential sensitivity of mouse epithelial tissues to the polyomavirus middle T oncogene.
Volume: 168
Issue: 1
Pages: 310-20
Publication
First Author: Hafeez BB
Year: 2016
Journal: Oncotarget
Title: Tissue-specific conditional PKCε knockout mice: a model to precisely reveal PKCε functional role in initiation, promotion and progression of cancer.
Volume: 7
Issue: 22
Pages: 33069-80
Publication
First Author: Bezzi M
Year: 2018
Journal: Nat Med
Title: Diverse genetic-driven immune landscapes dictate tumor progression through distinct mechanisms.
Volume: 24
Issue: 2
Pages: 165-175
Publication
First Author: Ahn S
Year: 2022
Journal: Oncogene
Title: CXCR4 and CXCR7 signaling promotes tumor progression and obesity-associated epithelial-mesenchymal transition in prostate cancer cells.
Volume: 41
Issue: 41
Pages: 4633-4644
Publication
First Author: Cai H
Year: 2024
Journal: Nat Commun
Title: CRISPR/Cas9 model of prostate cancer identifies Kmt2c deficiency as a metastatic driver by Odam/Cabs1 gene cluster expression.
Volume: 15
Issue: 1
Pages: 2088
Publication
First Author: Belair CD
Year: 2015
Journal: EMBO Rep
Title: DGCR8 is essential for tumor progression following PTEN loss in the prostate.
Volume: 16
Issue: 9
Pages: 1219-32
Publication
First Author: Ruetten H
Year: 2020
Journal: Am J Physiol Renal Physiol
Title: Impact of sex, androgens, and prostate size on C57BL/6J mouse urinary physiology: urethral histology.
Volume: 318
Issue: 3
Pages: F617-F627
Publication
First Author: Li F
Year: 2020
Journal: J Clin Invest
Title: ERG orchestrates chromatin interactions to drive prostate cell fate reprogramming.
Volume: 130
Issue: 11
Pages: 5924-5941
Publication
First Author: Jin C
Year: 2003
Journal: Cancer Res
Title: Cooperation between ectopic FGFR1 and depression of FGFR2 in induction of prostatic intraepithelial neoplasia in the mouse prostate.
Volume: 63
Issue: 24
Pages: 8784-90
Publication
First Author: Mulholland DJ
Year: 2011
Journal: Cancer Cell
Title: Cell autonomous role of PTEN in regulating castration-resistant prostate cancer growth.
Volume: 19
Issue: 6
Pages: 792-804
Publication
First Author: Nair VS
Year: 2014
Journal: Biochem Biophys Res Commun
Title: Down-regulation of Tet2 prevents TSDR demethylation in IL2 deficient regulatory T cells.
Volume: 450
Issue: 1
Pages: 918-24
Publication
First Author: Sun H
Year: 2011
Journal: Proc Natl Acad Sci U S A
Title: E2f binding-deficient Rb1 protein suppresses prostate tumor progression in vivo.
Volume: 108
Issue: 2
Pages: 704-9
Publication
First Author: Mao J
Year: 2006
Journal: Cancer Res
Title: A novel somatic mouse model to survey tumorigenic potential applied to the Hedgehog pathway.
Volume: 66
Issue: 20
Pages: 10171-8
Publication
First Author: Klein RD
Year: 2005
Journal: Mutat Res
Title: The use of genetically engineered mouse models of prostate cancer for nutrition and cancer chemoprevention research.
Volume: 576
Issue: 1-2
Pages: 111-9
Publication
First Author: He Y
Year: 2020
Journal: Oncogene
Title: Androgen receptor with short polyglutamine tract preferably enhances Wnt/β-catenin-mediated prostatic tumorigenesis.
Volume: 39
Issue: 16
Pages: 3276-3291
Publication
First Author: Patel R
Year: 2020
Journal: Cancer Res
Title: Activation of β-Catenin Cooperates with Loss of Pten to Drive AR-Independent Castration-Resistant Prostate Cancer.
Volume: 80
Issue: 3
Pages: 576-590
Publication
First Author: Berquin IM
Year: 2007
Journal: J Clin Invest
Title: Modulation of prostate cancer genetic risk by omega-3 and omega-6 fatty acids.
Volume: 117
Issue: 7
Pages: 1866-75
Publication
First Author: Wu X
Year: 2011
Journal: Dev Biol
Title: Differentiation of the ductal epithelium and smooth muscle in the prostate gland are regulated by the Notch/PTEN-dependent mechanism.
Volume: 356
Issue: 2
Pages: 337-49
Publication
First Author: Klezovitch O
Year: 2008
Journal: Proc Natl Acad Sci U S A
Title: A causal role for ERG in neoplastic transformation of prostate epithelium.
Volume: 105
Issue: 6
Pages: 2105-10
Publication
First Author: Blee AM
Year: 2018
Journal: Clin Cancer Res
Title: TMPRSS2-ERG Controls Luminal Epithelial Lineage and Antiandrogen Sensitivity in PTEN and TP53-Mutated Prostate Cancer.
Volume: 24
Issue: 18
Pages: 4551-4565
Publication
First Author: Lu X
Year: 2017
Journal: Nature
Title: Effective combinatorial immunotherapy for castration-resistant prostate cancer.
Volume: 543
Issue: 7647
Pages: 728-732
Publication  
First Author: Ku SY
Year: 2024
Journal: J Clin Invest
Title: Notch signaling suppresses neuroendocrine differentiation and alters the immune microenvironment in advanced prostate cancer.
Volume: 134
Issue: 17
Publication
First Author: Kim J
Year: 2012
Journal: Oncogene
Title: A mouse model of heterogeneous, c-MYC-initiated prostate cancer with loss of Pten and p53.
Volume: 31
Issue: 3
Pages: 322-32
Publication
First Author: Ku SY
Year: 2017
Journal: Science
Title: Rb1 and Trp53 cooperate to suppress prostate cancer lineage plasticity, metastasis, and antiandrogen resistance.
Volume: 355
Issue: 6320
Pages: 78-83
Publication
First Author: El-Kenawi A
Year: 2021
Journal: Cancer Res
Title: Macrophage-Derived Cholesterol Contributes to Therapeutic Resistance in Prostate Cancer.
Volume: 81
Issue: 21
Pages: 5477-5490
Publication
First Author: Liao CP
Year: 2007
Journal: Cancer Res
Title: Mouse models of prostate adenocarcinoma with the capacity to monitor spontaneous carcinogenesis by bioluminescence or fluorescence.
Volume: 67
Issue: 15
Pages: 7525-33
Publication
First Author: Calì B
Year: 2024
Journal: Cancer Cell
Title: Coagulation factor X promotes resistance to androgen-deprivation therapy in prostate cancer.
Volume: 42
Issue: 10
Pages: 1676-1692.e11
Publication
First Author: Nazarian A
Year: 2014
Journal: Mol Cell Proteomics
Title: Inhibition of circulating dipeptidyl peptidase 4 activity in patients with metastatic prostate cancer.
Volume: 13
Issue: 11
Pages: 3082-96
Publication
First Author: Guertin DA
Year: 2009
Journal: Cancer Cell
Title: mTOR complex 2 is required for the development of prostate cancer induced by Pten loss in mice.
Volume: 15
Issue: 2
Pages: 148-59
Publication
First Author: Bianchi-Frias D
Year: 2015
Journal: Mol Cancer Res
Title: The landscape of somatic chromosomal copy number aberrations in GEM models of prostate carcinoma.
Volume: 13
Issue: 2
Pages: 339-47
Publication
First Author: Manda KR
Year: 2016
Journal: Oncogene
Title: NFATc1 promotes prostate tumorigenesis and overcomes PTEN loss-induced senescence.
Volume: 35
Issue: 25
Pages: 3282-92
Publication
First Author: Augello MA
Year: 2019
Journal: Cancer Cell
Title: CHD1 Loss Alters AR Binding at Lineage-Specific Enhancers and Modulates Distinct Transcriptional Programs to Drive Prostate Tumorigenesis.
Volume: 35
Issue: 4
Pages: 603-617.e8
Publication
First Author: Ahmad I
Year: 2016
Journal: Proc Natl Acad Sci U S A
Title: Sleeping Beauty screen reveals Pparg activation in metastatic prostate cancer.
Volume: 113
Issue: 29
Pages: 8290-5
Publication
First Author: Olson A
Year: 2019
Journal: PLoS Genet
Title: The comprehensive role of E-cadherin in maintaining prostatic epithelial integrity during oncogenic transformation and tumor progression.
Volume: 15
Issue: 10
Pages: e1008451
Publication
First Author: Gu Z
Year: 2013
Journal: Carcinogenesis
Title: Polyunsaturated fatty acids affect the localization and signaling of PIP3/AKT in prostate cancer cells.
Volume: 34
Issue: 9
Pages: 1968-75
Publication
First Author: Palian BM
Year: 2014
Journal: PLoS Genet
Title: Maf1 is a novel target of PTEN and PI3K signaling that negatively regulates oncogenesis and lipid metabolism.
Volume: 10
Issue: 12
Pages: e1004789
Publication
First Author: Kim J
Year: 2009
Journal: PLoS Genet
Title: Interactions between cells with distinct mutations in c-MYC and Pten in prostate cancer.
Volume: 5
Issue: 7
Pages: e1000542
Publication
First Author: Vitari AC
Year: 2011
Journal: Nature
Title: COP1 is a tumour suppressor that causes degradation of ETS transcription factors.
Volume: 474
Issue: 7351
Pages: 403-6
Publication
First Author: Tibbo AJ
Year: 2023
Journal: Br J Cancer
Title: MBTPS2 acts as a regulator of lipogenesis and cholesterol synthesis through SREBP signalling in prostate cancer.
Volume: 128
Issue: 11
Pages: 1991-1999
Publication
First Author: Linn DE
Year: 2016
Journal: Cancer Res
Title: Deletion of Interstitial Genes between TMPRSS2 and ERG Promotes Prostate Cancer Progression.
Volume: 76
Issue: 7
Pages: 1869-81
Publication
First Author: Ahmad I
Year: 2011
Journal: Proc Natl Acad Sci U S A
Title: HER2 overcomes PTEN (loss)-induced senescence to cause aggressive prostate cancer.
Volume: 108
Issue: 39
Pages: 16392-7
Publication
First Author: Bolt CC
Year: 2016
Journal: PLoS One
Title: Tbx18 Regulates the Differentiation of Periductal Smooth Muscle Stroma and the Maintenance of Epithelial Integrity in the Prostate.
Volume: 11
Issue: 4
Pages: e0154413
Publication
First Author: Song Y
Year: 2017
Journal: PLoS One
Title: RB inactivation in keratin 18 positive thymic epithelial cells promotes non-cell autonomous T cell hyperproliferation in genetically engineered mice.
Volume: 12
Issue: 2
Pages: e0171510
Publication
First Author: Nguyen LT
Year: 2015
Journal: Cancer Cell
Title: ERG Activates the YAP1 Transcriptional Program and Induces the Development of Age-Related Prostate Tumors.
Volume: 27
Issue: 6
Pages: 797-808
Publication  
First Author: Stellas D
Year: 2014
Journal: J Natl Cancer Inst
Title: Therapeutic effects of an anti-Myc drug on mouse pancreatic cancer.
Volume: 106
Issue: 12
Publication
First Author: Lu X
Year: 2017
Journal: Genes Dev
Title: Opposing roles of TGFβ and BMP signaling in prostate cancer development.
Volume: 31
Issue: 23-24
Pages: 2337-2342
Publication
First Author: Li Z
Year: 2023
Journal: Oncogene
Title: The DACH1 gene is frequently deleted in prostate cancer, restrains prostatic intraepithelial neoplasia, decreases DNA damage repair, and predicts therapy responses.
Volume: 42
Issue: 22
Pages: 1857-1873
Publication
First Author: Birbach A
Year: 2009
Journal: Genesis
Title: A Probasin-MerCreMer BAC allows inducible recombination in the mouse prostate.
Volume: 47
Issue: 11
Pages: 757-64
Publication
First Author: Kim WK
Year: 2022
Journal: Nat Commun
Title: Aberrant androgen action in prostatic progenitor cells induces oncogenesis and tumor development through IGF1 and Wnt axes.
Volume: 13
Issue: 1
Pages: 4364
Publication
First Author: Clegg NJ
Year: 2011
Journal: PLoS One
Title: MYC cooperates with AKT in prostate tumorigenesis and alters sensitivity to mTOR inhibitors.
Volume: 6
Issue: 3
Pages: e17449
Publication
First Author: Anderson PD
Year: 2012
Journal: J Clin Invest
Title: Nkx3.1 and Myc crossregulate shared target genes in mouse and human prostate tumorigenesis.
Volume: 122
Issue: 5
Pages: 1907-19
Publication
First Author: Roh M
Year: 2006
Journal: Genesis
Title: Transgenic mice for Cre-inducible overexpression of the oncogenes c-MYC and Pim-1 in multiple tissues.
Volume: 44
Issue: 10
Pages: 447-53
Publication
First Author: Li G
Year: 2020
Journal: Cancer Res
Title: KDM5B Is Essential for the Hyperactivation of PI3K/AKT Signaling in Prostate Tumorigenesis.
Volume: 80
Issue: 21
Pages: 4633-4643
Publication
First Author: Wegner KA
Year: 2017
Journal: PLoS One
Title: An immunohistochemical identification key for cell types in adult mouse prostatic and urethral tissue sections.
Volume: 12
Issue: 11
Pages: e0188413
Publication
First Author: Bancaro N
Year: 2023
Journal: Cancer Cell
Title: Apolipoprotein E induces pathogenic senescent-like myeloid cells in prostate cancer.
Volume: 41
Issue: 3
Pages: 602-619.e11
Publication
First Author: Huang T
Year: 2020
Journal: Nat Commun
Title: Effective combinatorial immunotherapy for penile squamous cell carcinoma.
Volume: 11
Issue: 1
Pages: 2124
Publication
First Author: Davidson SM
Year: 2022
Journal: Cancer Res
Title: Pyruvate Kinase M1 Suppresses Development and Progression of Prostate Adenocarcinoma.
Volume: 82
Issue: 13
Pages: 2403-2416
Publication
First Author: Moose DL
Year: 2020
Journal: Cell Rep
Title: Cancer Cells Resist Mechanical Destruction in Circulation via RhoA/Actomyosin-Dependent Mechano-Adaptation.
Volume: 30
Issue: 11
Pages: 3864-3874.e6
Publication
First Author: Yong C
Year: 2020
Journal: PLoS One
Title: Locally invasive, castrate-resistant prostate cancer in a Pten/Trp53 double knockout mouse model of prostate cancer monitored with non-invasive bioluminescent imaging.
Volume: 15
Issue: 9
Pages: e0232807
Publication
First Author: Svensson RU
Year: 2011
Journal: Am J Pathol
Title: Slow disease progression in a C57BL/6 pten-deficient mouse model of prostate cancer.
Volume: 179
Issue: 1
Pages: 502-12
Publication
First Author: Ammirante M
Year: 2010
Journal: Nature
Title: B-cell-derived lymphotoxin promotes castration-resistant prostate cancer.
Volume: 464
Issue: 7286
Pages: 302-5
Publication
First Author: Yoshioka T
Year: 2013
Journal: J Clin Invest
Title: β4 Integrin signaling induces expansion of prostate tumor progenitors.
Volume: 123
Issue: 2
Pages: 682-99
Publication
First Author: Hübner A
Year: 2012
Journal: Proc Natl Acad Sci U S A
Title: JNK and PTEN cooperatively control the development of invasive adenocarcinoma of the prostate.
Volume: 109
Issue: 30
Pages: 12046-51
Publication
First Author: Mulholland DJ
Year: 2012
Journal: Cancer Res
Title: Pten loss and RAS/MAPK activation cooperate to promote EMT and metastasis initiated from prostate cancer stem/progenitor cells.
Volume: 72
Issue: 7
Pages: 1878-89